Experienced Hands at The Helm

Gerald Minkowitz, MD, Co-Founder and Chairman is a visionary pathologist and pioneer in clinical use of digital medical systems.  Gerald earned his BS in Bioengineering in the Chemical Engineering Department of Columbia University School of Engineering and Applied Science in New York.  He completed his MD at New York Medical College, Valhalla, New York, and fulfilled his Residency requirements at New York Hospital-Cornell Medical Center specializing in Anatomic and Clinical Pathology.  He continued his Fellowship at Lankenau Hospital, Wynnewood, PA, concentrating in Cytopathology. Gerald holds academic affiliations with NYU School of Medicine and Columbia University College of Physicians and Surgeons and is currently Medical Director at Minkowitz Pathology, PC in New York. 

Gerald has been practicing medicine since 1987 and is board certified in anatomic pathology, clinical pathology, and cytopathology. Gerald's private practice serves patients across the greater New York metropolitan area.  Using his background in engineering, Gerald has successfully deployed digital pathology technology to improve his patient throughput and case turnaround time, as well as live consults with other physicians.  These direct experiences have influenced Gerald's ambition to expand the reach and utility of all types of remote diagnostic capabilities using secure web technologies.

Jeremy Kagan, MSc, Co-Founder and CEO is a technology executive with experience in identity management and real-time secure authorization using the web and mobile.  In a previous role Jeremy led his company in bringing to market an award winning technical innovation that  pioneered on-demand internet transaction processing using any web device such as a computer, tablet or smartphone.  Bringing a web product live across 63 countries by verifying identity, ensuring security, privacy and accuracy, and assuring regulatory compliance for cross-border financial transactions gave Jeremy a unique appreciation for the various challenges that face technology deployments in developed and in developing countries.  In a different previous role, Jeremy scaled the operational infrastructure of a long distance telephone company to support its growth in revenue from $3 Million/month to $36 Million/month within 2 years.

Jeremy honed his management skills and business development experience at leading global IT and Telecom companies including Telcordia, Accenture, Nokia Siemens Networks, and eBIZ.mobility.  Jeremy holds several patents and is a published author on the subject of mobile payments.  He earned a Master of Science degree in Operations Research from Columbia University School of Engineering and Applied Science and a Bachelor of Arts in Applied Mathematics from Queens College City University of New York. 

Andrew Goldman, MEng, Head of Software Development is a motivator of software engineers to deliver production level software that corresponds to the business requirements.

Andrew earned his MEng degree in Software Engineering from Imperial College, London in 1990, and has since been developing software for a wide range of systems and applications. Andrew's experience includes working on the leading edge conditional access software for Digital Television at NDA (now CISCO), as well as CTO and Founder of a start-up in the area of security of online data assets. More recently, Andrew has been focusing his engineering, development, and management skills on helping early stage technology up-starts transform their ideas and concepts into functional systems. 

​Tomer Assis, CPA, CFO
 brings with him over 15 years of extensive international business, financial and operating management experience in the high tech field from leading international public and private companies.

Tomer's experience includes serving as the CFO at NYGI Inc. (formerly known as InkSure Technologies Inc., OTC: INK), specialized in comprehensive security solutions, designed to protect branded products and documents of value from counterfeiting, fraud, and diversion and as the CFO of Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading molecular diagnostics company advancing microRNA-based diagnostics discovered and developed through its proprietary microRNAs and platform technologies. Tomer also served as the CFO at BackWeb Technologies Ltd., (OTC Pink: BWEBF) which provides communication technologies and solutions for the distribution of digital information and assets to enterprise’s employees and customers. Prior to joining BackWeb, Tomer served as the Director of Finance at CellNet Solutions Ltd., as the International Controller for Check Point Software Technologies Ltd. (NASDAQ: CHKP), and as the Controller for M+W Zander Group’s Israeli subsidiaries. Tomer has also worked at the accounting firms Ernst & Young and Grant Thornton in Israel.

Tomer is a Certified Public Accountant. He holds a B.B. in Business Administration, Accounting and Finance from The College of Management in Israel and graduated of the Program for Directors & Executives in corporations, Tel Aviv University.

Medical Advisory Board

Danny (Dan) Milner, MD, Medical Advisory Board Member
, is a Pathologist at Brigham and Women's Hospital and Associate Professor of Pathology (Harvard Medical School) and Immunology and Infectious Diseases (Harvard School of Public Health). He is an expert in infectious disease pathology, microbiology, and autopsy pathology.

Dr. Milner has extensive experience working in both research and global health capacitation in more than 10 African countries, and is a pioneer in the use of digital pathology to improve patient care and medical education in low income countries.

​Matthew T. Olson, MD, Medical Advisory Board Member,
is an Assistant Professor of Pathology, Johns Hopkins University School of Medicine; Staff Pathologist, The Johns Hopkins Hospital; Staff Pathologist, The Johns Hopkins Bayview Medical Center. His areas of clinical expertise include pathology with a focus in clinical chemistry and bioinformatics.

Dr. Olson wrote the code for Pyromaker, an easy-to-use online computer software application that can quickly and cheaply analyze normal and mutant DNA in tumor samples to help identify meaningful gene mutations.  He is certified in anatomic and clinical pathology by the American Board of Pathology.